Antimicrobial Resistance content hub

UICC resources and information on antimicrobial resistance

This page regroups important resources on antimicrobial resistance, material for UICC's members and partners, infographics, videos and other important documents and links.

The threat of antimicrobial resistance to cancer treatment and survival is a priority for UICC. Currently, knowledge and awareness of the impact of antimicrobial resistance on cancer outcomes within the cancer community is low. It is urgent that oncology professionals, cancer advocates, programme managers, patient groups and other stakeholders working in the field of cancer understand and address the factors that contribute to the development and spread of AMR and strategies for infection control.

In this regard, UICC will develop information to increase awareness and support the cancer community to come together and drive policy change, taking forward the WHO global action plan on antimicrobial resistance.

AMR Infographics and graphs

How antibiotic resistance develops

Antibiotics get less effective

Antibiotics help our bodies to kill the types of bacteria that make us sick.

Antibiotic resistance

Some of the bacteria that make us sick get better at defending themselves against antibiotics, meaning resistant bacteria are harder to kill. This is called antibiotic resistance.​

Antibiotics help our bodies to kill bacteria that makes us sick

The resistant bacteria start to multiply, making our antibiotics less and less effective.

Image source: PHARMAC, NZ -

Causes of antimicrobial resistance

AMR news & blogs

Bacteria Staphylococcus aureus on the surface of skin or mucous membrane. Staphylococcus aureus can be highly resistance to antibiotics.
30 July 2021

Improving tools for combatting antimicrobial resistance

Diane Flayart at UICC's partner BD looks at common needs and interventions for COVID-19 and AMR and how to apply learnings from the COVID-19 pandemic to the global challenge of drug-resistant infections.

Virtual meeting of the 74th World Health Assembly
10 June 2021

The 74th World Health Assembly focuses on resilience and equity

At WHA74, participants examined the global response to COVID-19, future pandemic preparedness, equitable access to medicines, social determinants of health and antimicrobial resistance.

Person holding a blister pack of medicine
17 May 2021

Cancer treatment threatened by increasingly ineffective antimicrobial drugs

As pathogens become ever more resistant to antimicrobial drugs such as antibiotics, people living with cancer run a growing risk of adverse treatment outcomes, including death from an infection, even though their cancer is treatable.

Antibiotic resistance is among the many challenges facing the ability of countries in Sub-Saharan Africa to properly manage cancer patients
24 November 2020

The impact of AMR on cancer care in Sub-Saharan Africa

To mark World Antimicrobial Awareness Week, Mirfin Mpundu and Zipporah Ali share their views on the impact of AMR on cancer care outcomes in Sub-Saharan Africa and why urgent action is required to address this threat. 

The significant and growing threat of antibiotic resistance is severely undermining the ability of health practitioners to treat cancer.
16 November 2020

Drug resistance threatens the future of cancer care: what can be done?

Marking World Antimicrobial Awareness Week, Manica Balasegaram explains why urgent action is required to address the threat that drug resistance poses to cancer care.

Antimicrobial resistance threatens cancer care
7 July 2020

The impending public health crisis of antimicrobial resistance

The growing resistance of microbes to medicines that are designed to fight off infections threatens to strain health systems worldwide and could seriously compromise better cancer treatment outcomes.

AMR external documents & links

Useful links for further reading


Last update: 
Friday 28 May 2021